Valuation: Navamedic ASA

Market Cap 405M 41.35M 36.27M 33.48M 30.94M 58.64M 3.96B 59.82M 402M 156M 1.94B 155M 152M 6.73B P/E 2026 *
-307x
P/E 2027 * 38x
Enterprise Value 525M 53.59M 47M 43.39M 40.1M 76.01M 5.13B 77.53M 522M 203M 2.51B 201M 197M 8.72B EV / Sales 2026 *
0.89x
EV / Sales 2027 * 0.77x
Free-Float
74.67%
Yield 2026 *
-
Yield 2027 * -
1 day+0.90%
1 week+3.36%
Current month+3.36%
1 month-0.29%
3 months-17.16%
6 months-24.89%
Current year-28.99%
1 week 16.4
Extreme 16.4
17.45
1 month 15.7
Extreme 15.7
17.55
Current year 15.7
Extreme 15.7
24.5
1 year 15.7
Extreme 15.7
27.9
3 years 15.7
Extreme 15.7
43.9
5 years 15.7
Extreme 15.7
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 60 01/01/2019
Director of Finance/CFO - 01/01/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 54 01/06/2022
Director/Board Member - 01/06/2023
Director/Board Member 60 01/06/2024
Date Insider Type Main position Quantity % Market Cap.
19/12/24Buy

Chief Operating Officer

10,267 0.0581%
09/09/24Fiscal year

Chief Executive Officer

80,000 0.4589%
09/09/24Fiscal year

Executive/Senior Manager

75,000 0.4302%
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%+3.36%-23.53%-55.87% 41.35M
-1.60%+2.02%+56.34%+168.94% 1,084B
-1.44%+3.71%+69.07%+65.40% 634B
-0.75%+0.67%+33.18%+86.52% 447B
-1.35%+1.86%+29.96%+26.28% 330B
-0.86%+2.79%+37.72%+40.85% 295B
-0.71%+0.72%+28.85%+48.27% 285B
-1.31%-0.26%-28.18%-39.82% 218B
-0.03%+1.84%+23.90%+68.30% 199B
-0.40%+7.82%+22.29%+82.50% 169B
Average -0.76%+2.60%+24.96%+49.14% 365.99B
Weighted average by Cap. -1.16%+2.48%+41.34%+86.49%

Financials

2026 *2027 *
Net sales 588M 59.97M 52.6M 48.56M 44.88M 85.06M 5.74B 86.76M 584M 227M 2.81B 225M 220M 9.76B 643M 65.64M 57.58M 53.16M 49.12M 93.1M 6.29B 94.97M 639M 248M 3.08B 247M 241M 10.68B
Net income -1.5M -153K -134K -124K -114K -216K -14.6M -221K -1.48M -577K -7.15M -573K -560K -24.81M 10.7M 1.09M 957K 884K 817K 1.55M 105M 1.58M 10.63M 4.13M 51.15M 4.1M 4.01M 178M
Net Debt 120M 12.24M 10.74M 9.91M 9.16M 17.36M 1.17B 17.71M 119M 46.31M 574M 45.97M 44.97M 1.99B 87.4M 8.92M 7.82M 7.22M 6.67M 12.65M 854M 12.9M 86.8M 33.73M 418M 33.48M 32.75M 1.45B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
08/07/26 NOK 16.90 +0.90% 7,799
07/07/26 NOK 16.75 -2.33% 1,522
06/07/26 NOK 17.15 +0.88% 10,304
03/07/26 NOK 17.00 +4.94% 30,323
02/07/26 NOK 16.20 -0.92% 147
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.90NOK
Average target price
23.50NOK
Spread / Average Target
+39.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock